Website intended for a NZ health professional readership
The number of people taking funded dulaglutide (Trulicity) has doubled in New Zealand over the past two years and the diabetes medicine is in short supply again, along with its alternative, Victoza (liraglutide). Natasha Jojoa Burling reports
Kia ora and welcome to Pharmacy Today Kaitiaki Rongoā O Te Wā
Not a subscriber? Unlock this article by subscribing here.
Academic pharmacist Nataly Martini discusses the medical management of asthma in adults and adolescents, which has evolved to prioritise early anti-inflammatory treatment. She also explains how to improve patient outcomes by proactively identifying poor asthma control and supporting equitable access to education and treatment
Ever heard these myths from smokers?
